ImmunoGen, Inc. (IMGN): insider trading, Congress trades & who owns it

Insider signal
50/100
Neutral · 90 days
Insider buys
$0
0 buyers · 12 months
Insider sales
$0
0 sellers · 12 months
Funds holding
—
13F filings
Congress trades
None
none in 2 years

Quiet on the insider front: nobody at ImmunoGen, Inc. bought or sold IMGN shares on the open market this past year.

No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.

Want the full picture on IMGN? Price & valuation, financials by quarter, who owns it, dilution, earnings and a written bull & bear case. See what's inside ↓
See the full IMGN report — free account

Latest insider trades in IMGN

FiledInsiderRoleTypeSharesPriceValueSource
Feb 6, 2024Coen Stacy AnnExecutive OfficerSell4,583$29.30$134KSEC
Feb 6, 2024Wingrove TheresaExecutive OfficerSell12,027$29.30$352KSEC
Feb 6, 2024Enyedy Mark JCEOSell20,107$29.28$589KSEC
Feb 6, 2024Lentini ReneeOfficerSell2,631$29.30$77KSEC
Jan 18, 2024Wingrove TheresaExecutive OfficerSell187,667$29.64$5.6MSEC
Dec 27, 2023Lentini ReneeOfficerSell6,548$29.74$195KSEC
Dec 19, 2023Wingrove TheresaExecutive OfficerSell117,445$29.40$3.5MSEC
Dec 5, 2023Coen Stacy AnnExecutive OfficerSell3,826$29.20$112KSEC
Dec 5, 2023Peterson KristineDirectorSell20,000$28.90$578KSEC
Dec 1, 2023Wingrove TheresaExecutive OfficerSell164,424$28.95$4.8MSEC
Dec 1, 2023Wingrove TheresaExecutive OfficerSell6,792$16.66$113KSEC
Nov 17, 2023Wingrove TheresaExecutive OfficerSell166,725$15.85$2.6MSEC
Nov 17, 2023Coen Stacy AnnExecutive OfficerSell4,100$16.01$66KSEC
Nov 17, 2023Coen Stacy AnnExecutive OfficerSell78,223$16.05$1.3MSEC
Nov 17, 2023Coen Stacy AnnExecutive OfficerSell26,286$16.01$421KSEC
The full IMGN report

This page shows the insider trades. The full IMGN report shows everything around them.

Price and valuation, revenue and profit by quarter, who owns it, dilution, earnings timing and a written bull & bear case, in one report you can also print or save as a PDF. Here is what each section looks like (screenshots from a real report):

CapitalSnitch report section: Live price & key numbers
Live price & key numbersScout

Price, market cap, P/E, revenue and profit growth at a glance.

CapitalSnitch report section: Bull case vs bear case
Bull case vs bear caseAnalyst

A written read of everything below: what supports the stock, what worries.

CapitalSnitch report section: Insider signal score
Insider signal scoreFree

A 0-100 score with the reasons, plus earnings date, volatility and analyst ratings (Analyst).

CapitalSnitch report section: Revenue & profit by quarter
Revenue & profit by quarterScout

Three years of results from SEC filings, growth marked quarter by quarter.

CapitalSnitch report section: Insider buying vs selling by quarter
Insider buying vs selling by quarterScout

Streaks like “7 quarters of net selling” spotted for you.

CapitalSnitch report section: Who owns it (13F)
Who owns it (13F)Scout

Top funds, who added, who cut and who sold out last quarter.

CapitalSnitch report section: Congress trades
Congress tradesFree

Every House and Senate trade in the stock, late filers flagged.

CapitalSnitch report section: Dilution tracker
Dilution trackerAnalyst

Stock offerings, shelf registrations and share-count growth, scored.

CapitalSnitch report section: Snapshot for your trading style
Snapshot for your trading styleAnalyst

Day trading, swing trading and long-term numbers side by side.

Free plan: insider trades, insider signal and Congress trades. Sections marked Scout or Analyst unlock with that plan (from $29/month). Screenshots: Micron Technology report, Oct 19, 2026.

Questions about IMGN

Are insiders buying or selling IMGN stock?

There were no open-market insider trades in IMGN in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.

Has any member of Congress traded IMGN?

No congressional trades in IMGN were reported in the past two years. The full list is free on CapitalSnitch.

Also active in insider buying

Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.

Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).